Literature DB >> 32783176

Recognition of cognitive complaints for patients with advanced cancer.

Denise Pergolizzi1, Iris Crespo2.   

Abstract

Fueled by increasing recognition that cancer-related cognitive impairment impacts quality of life among cancer survivors, we suggest that researchers and clinicians expand their focus to acknowledge the impact of cognitive changes for those with advanced cancer. We outline five reasons that patients with advanced cancer would benefit from comprehensive assessments that include questions about cognitive complaints. Advanced cancer has all the characteristics that would lead to cognitive changes. Patients with advanced cancer may have a higher risk for cognitive impairment due to aggressive chemotherapies, higher symptom burden, and greater psychosocial distress. This commentary contextualizes how cognitive complaints may relate to multiple factors relevant to the advanced cancer patient. By simply asking the patient about their perceived cognitive changes, we argue this may be a stepping stone to finding non-pharmacological ways to address cognitive impairment.

Entities:  

Keywords:  Advanced cancer; Cognitive complaints; Palliative and supportive care; Quality of life

Mesh:

Year:  2020        PMID: 32783176     DOI: 10.1007/s00520-020-05678-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  12 in total

Review 1.  The reliability theory of aging and longevity.

Authors:  L A Gavrilov; N S Gavrilova
Journal:  J Theor Biol       Date:  2001-12-21       Impact factor: 2.691

2.  Outcome over seven years of healthy adults with and without subjective cognitive impairment.

Authors:  Barry Reisberg; Melanie B Shulman; Carol Torossian; Ling Leng; Wei Zhu
Journal:  Alzheimers Dement       Date:  2010-01       Impact factor: 21.566

Review 3.  Chemobrain: a systematic review of structural and functional neuroimaging studies.

Authors:  Marta Simó; Xavier Rifà-Ros; Antoni Rodriguez-Fornells; Jordi Bruna
Journal:  Neurosci Biobehav Rev       Date:  2013-05-06       Impact factor: 8.989

4.  Subjective Cognitive Decline: Mapping Functional and Structural Brain Changes-A Combined Resting-State Functional and Structural MR Imaging Study.

Authors:  Yu Sun; Zhengjia Dai; Yuxia Li; Can Sheng; Hongyan Li; Xiaoni Wang; Xiaodan Chen; Yong He; Ying Han
Journal:  Radiology       Date:  2016-03-22       Impact factor: 11.105

5.  Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.

Authors:  Geana P Kurita; Per Sjøgren; Ola Ekholm; Stein Kaasa; Jon H Loge; Irena Poviloniene; Pål Klepstad
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

6.  Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients.

Authors:  Michelle Lycke; Tessa Lefebvre; Lies Pottel; Hans Pottel; Lore Ketelaars; Karin Stellamans; Koen Van Eygen; Philippe Vergauwe; Patrick Werbrouck; Lieselot Cool; Tom Boterberg; Nick Liefhooghe; Patricia Schofield; Philip R Debruyne
Journal:  J Psychosoc Oncol       Date:  2019-02-23

Review 7.  Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review.

Authors:  Amanda D Hutchinson; Jessica R Hosking; Ganessan Kichenadasse; Julie K Mattiske; Carlene Wilson
Journal:  Cancer Treat Rev       Date:  2012-06-02       Impact factor: 12.111

8.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Authors:  Ethan Basch; Allison M Deal; Mark G Kris; Howard I Scher; Clifford A Hudis; Paul Sabbatini; Lauren Rogak; Antonia V Bennett; Amylou C Dueck; Thomas M Atkinson; Joanne F Chou; Dorothy Dulko; Laura Sit; Allison Barz; Paul Novotny; Michael Fruscione; Jeff A Sloan; Deborah Schrag
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

9.  Unrecognised cognitive impairment in hospice patients: a pilot study.

Authors:  S A Irwin; C H Zurhellen; L C Diamond; L B Dunn; B W Palmer; D V Jeste; E W Twamley
Journal:  Palliat Med       Date:  2008-09-04       Impact factor: 4.762

Review 10.  Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

Authors:  Tim A Ahles; James C Root; Elizabeth L Ryan
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

View more
  1 in total

1.  Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations from the Cancer Neuroscience Initiative Working Group.

Authors:  Ashley M Henneghan; Kathleen Van Dyk; Tara Kaufmann; Rebecca Harrison; Christopher Gibbons; Cobi Heijnen; Shelli R Kesler
Journal:  J Natl Cancer Inst       Date:  2021-02-26       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.